News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
381,255 Results
Type
Article (25913)
Company Profile (59)
Press Release (355283)
Multimedia
Podcasts (25)
Webinars (7)
Section
Business (104253)
Career Advice (449)
Deals (16871)
Drug Delivery (51)
Drug Development (47592)
Employer Resources (47)
FDA (12261)
Job Trends (8439)
News (185913)
Policy (19419)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (2)
2024 Biotech Bay Standard (5)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (2)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (1750)
Accelerated approval (3)
Adcomms (8)
Allergies (70)
Alliances (26736)
ALS (56)
Alzheimer's disease (808)
Antibody-drug conjugate (ADC) (50)
Approvals (12320)
Artificial intelligence (163)
Autoimmune disease (10)
Automation (4)
Bankruptcy (142)
Best Places to Work (6892)
BIOSECURE Act (5)
Biosimilars (36)
Biotechnology (39)
Bladder cancer (51)
Brain cancer (17)
Breast cancer (187)
Cancer (1369)
Cardiovascular disease (116)
Career advice (407)
Career pathing (13)
CAR-T (67)
Cell therapy (192)
Cervical cancer (13)
Clinical research (40459)
Collaboration (431)
Compensation (126)
Complete response letters (9)
COVID-19 (1490)
CRISPR (11)
C-suite (135)
Cystic fibrosis (42)
Data (1448)
Decentralized trials (2)
Denatured (17)
Depression (30)
Diabetes (170)
Diagnostics (3512)
Digital health (11)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (52)
Drug pricing (54)
Drug shortages (21)
Duchenne muscular dystrophy (54)
Earnings (36827)
Editorial (19)
Employer branding (6)
Employer resources (44)
Events (51662)
Executive appointments (438)
FDA (13218)
Featured Employer (14)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (3)
Funding (396)
Gene editing (35)
Generative AI (10)
Gene therapy (125)
GLP-1 (397)
Government (3032)
Grass and pollen (3)
Guidances (36)
Healthcare (12185)
Huntington's disease (10)
IgA nephropathy (15)
Immunology and inflammation (39)
Indications (18)
Infectious disease (1560)
Inflammatory bowel disease (78)
Inflation Reduction Act (4)
Influenza (26)
Intellectual property (48)
Interviews (40)
IPO (7035)
IRA (19)
Job creations (1838)
Job search strategy (378)
Kidney cancer (7)
Labor market (10)
Layoffs (168)
Leadership (4)
Legal (3632)
Liver cancer (55)
Lung cancer (226)
Lymphoma (93)
Machine learning (2)
Management (17)
Manufacturing (102)
MASH (46)
Medical device (12888)
Medtech (12891)
Mergers & acquisitions (10120)
Metabolic disorders (421)
Multiple sclerosis (53)
NASH (11)
Neurodegenerative disease (47)
Neuropsychiatric disorders (9)
Neuroscience (1130)
NextGen: Class of 2025 (3930)
Non-profit (2820)
Northern California (1302)
Now hiring (16)
Obesity (216)
Opinion (70)
Ovarian cancer (50)
Pain (61)
Pancreatic cancer (53)
Parkinson's disease (87)
Partnered (11)
Patents (108)
Patient recruitment (76)
Peanut (37)
People (34685)
Pharmaceutical (17)
Pharmacy benefit managers (11)
Phase I (11589)
Phase II (17512)
Phase III (14395)
Pipeline (653)
Policy (59)
Postmarket research (1668)
Preclinical (3599)
Press Release (18)
Prostate cancer (72)
Psychedelics (17)
Radiopharmaceuticals (160)
Rare diseases (179)
Real estate (2845)
Recruiting (16)
Regulatory (14182)
Reports (16)
Research institute (1606)
Resumes & cover letters (48)
Rett syndrome (2)
RNA editing (2)
RSV (20)
Schizophrenia (48)
Series A (64)
Series B (46)
Service/supplier (3)
Sickle cell disease (21)
Southern California (1141)
Special edition (3)
Spinal muscular atrophy (102)
Sponsored (13)
Startups (2120)
Stomach cancer (8)
Supply chain (37)
Tariffs (9)
The Weekly (8)
United States (12445)
Vaccines (347)
Venture capitalists (13)
Weight loss (138)
Women's health (17)
Worklife (4)
Date
Today (18)
Last 7 days (336)
Last 30 days (1311)
Last 365 days (18467)
2025 (5446)
2024 (19848)
2023 (22736)
2022 (30680)
2021 (32984)
2020 (32190)
2019 (28412)
2018 (21810)
2017 (18906)
2016 (18111)
2015 (21194)
2014 (16023)
2013 (13241)
2012 (14349)
2011 (14622)
2010 (13181)
Location
Africa (354)
Alabama (17)
Alaska (2)
Arizona (117)
Arkansas (10)
Asia (24523)
Australia (3882)
California (2964)
Canada (1190)
China (357)
Colorado (161)
Connecticut (167)
Delaware (110)
Europe (47853)
Florida (525)
Georgia (124)
Idaho (33)
Illinois (351)
India (14)
Indiana (223)
Iowa (3)
Japan (116)
Kansas (72)
Kentucky (12)
Louisiana (7)
Maine (27)
Maryland (623)
Massachusetts (2080)
Michigan (104)
Minnesota (264)
Mississippi (2)
Missouri (52)
Montana (18)
Nebraska (18)
Nevada (30)
New Hampshire (59)
New Jersey (1091)
New Mexico (9)
New York (923)
North Carolina (546)
North Dakota (3)
Northern California (1302)
Ohio (128)
Oklahoma (3)
Oregon (23)
Pennsylvania (803)
Puerto Rico (7)
Rhode Island (24)
South America (520)
South Carolina (20)
Southern California (1141)
Tennessee (77)
Texas (521)
Utah (109)
Virginia (76)
Washington D.C. (39)
Washington State (224)
West Virginia (3)
Wisconsin (40)
381,255 Results for "bluewind medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BlueWind Medical Announces Peer-Reviewed Data Showing Excellent Durability of Results for Revi® System at Two Years
February 7, 2025
·
4 min read
Business
BlueWind Medical Appoints Lori Chmura as Chair of the Board of Directors
September 16, 2024
·
2 min read
Press Releases
BlueWind Medical Announces Favorable CMS Decision for 2025 Reimbursement Rates for Revi® System’s Implantable Tibial Neuromodulation Therapy
November 4, 2024
·
3 min read
BlueWind Medical Brings Revi™ Implantable Tibial Neuromodulation Device to Patients in Central Ohio
BlueWind Medical, Ltd., a pioneer in the development and commercialization of a patient centric implantable Tibial NeuroModulation (iTNM) solution for urge urinary incontinence (UUI), is excited to announce that Revi is now available in Springfield, Ohio at Ohio Valley Surgical Hospital with urologist Dr. Eric Espinosa.
February 7, 2024
·
3 min read
Press Releases
New Research from BlueWind Medical Shows Implantable Tibial Neuromodulation (iTNM), such as the Revi® System, as Effective Alternative to Sacral Neuromodulation (SNM) for Overactive Bladder and Urge Urinary Incontinence
October 31, 2024
·
4 min read
BlueWind Medical’s Revi™ System Secures U.S. FDA De Novo Classification Grant for the Treatment of Urgency Incontinence
BlueWind Medical, Ltd. today announced that the US Food and Drug Administration (FDA) granted a De Novo marketing request for the Revi System, a transformative tibial neuromodulation therapy for the treatment of the symptoms of urgency incontinence alone or in combination with urinary urgency.
August 17, 2023
·
4 min read
Business
BlueWind Medical Announces New Executive Appointments
BlueWind Medical, Ltd., a medical device company transforming neuromodulation therapy for overactive bladder, announced three executive appointments to leadership positions within the company.
November 1, 2022
·
4 min read
Clinical Study Results of the BlueWind System for Patients with Overactive Bladder Featured at the 2023 AUA Annual Meeting
BlueWind Medical, Ltd., the developer of a transformative implantable tibial neuromodulation therapy for Overactive Bladder (OAB), today announced results from the OASIS pivotal trial evaluating the safety and efficacy of the BlueWind System in the treatment of OAB.
May 1, 2023
·
4 min read
BioMidwest
BlueWind Medical Announces Key Milestone as AMA Issues Unique Category III CPT Code for Subfascial Placement of Tibial Neurostimulators
BlueWind Medical, Ltd. is pleased to announce that the American Medical Association has issued a new Current Procedural Terminology code for the subfascial implantation of a tibial neuromodulation device for Overactive Bladder.
March 8, 2023
·
4 min read
Business
BlueWind Medical Appoints Dr. Liz Kwo to Board of Directors
BlueWind Medical, Ltd. announced that Liz Kwo, M.D., MBA, MPH, Chief Medical Officer at Everly Health, has joined the company’s Board of Directors.
September 27, 2022
·
3 min read
1 of 38,126
Next
